Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

New hope for stroke prevention in patients who Can't take blood thinners

NCT ID NCT03111654

First seen Nov 19, 2025 · Last updated Jun 19, 2026 · Updated 27 times

Summary

This study tested a procedure to close a small pouch in the heart (the left atrial appendage) in people with atrial fibrillation who had a brain bleed and cannot use standard blood thinners. The goal was to see if this could prevent future strokes without causing another bleed. Researchers followed 58 patients over time to track their health outcomes.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ATRIAL FIBRILLATION are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Locations

  • CHU Amiens Picardie

    Amiens, Picardie, 80054, France

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance

percutaneous closure of the left atrial appendage

What this could lead to

If successful, this technique could offer a safe way to prevent strokes in atrial fibrillation patients who cannot take blood thinners due to a prior brain bleed.

What could go wrong

This is a small pilot study with only 58 participants, so results may not apply broadly. The procedure itself carries risks, and long-term benefits versus harms are still uncertain.

Conditions

The condition(s) this trial relates to.

atrial fibrillation intracerebral hemorrhage Intracranial Hemorrhages stroke disorder prevention target

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.